Table 3.
The relationship between sarcopenia and COPD findings.
| No sarcopenia | Sarcopenia | T | P | |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
| FEV1% | 47.6 ± 18.5 | 41.5 ± 16.9 | –2.560 | 0.011 |
| FEV1 - L | 1.4 ± 0.6 | 1.1 ± 0.5 | –3.735 | < 0.001 |
| FVC% | 57.0 ± 19.8 | 52.9 ± 18.8 | –1.555 | 0.121 |
| FVC - L | 2.1 ± 0.8 | 1.8 ± 0.7 | –2.819 | 0.005 |
| FEV1 / FVC | 63.2 ± 7.4 | 59.2 ± 8.9 | –3.654 | < 0.001 |
| mMRC | 1.56 ± 1.1 | 2.3 ± 1.0 | 5.035 | < 0.001 |
| BODE index | 3.5 ± 2.7 | 5.4 ± 2.7 | 5.140 | < 0.001 |
| Diagnosis time (year) | 6.9 ± 7.5 | 7.4 ± 6.7 | 0.417 | 0.677 |
| Hospitalizations / year | 1.55 ± 2.0 | 3.25 ± 5.1 | 3.160 | 0.002 |
| 6-MWT (meter) | 308.5 ± 123.4 | 237.9 ± 105.7 | –4.555 | < 0.001 |